Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease.
Marjolein DrentPetal A WijnenNaomi T JessurunAnkie M HarmszeOtto BekersAalt BastPublished in: Drug safety (2024)
ClinicalTrials.gov identifier NCT00267800, registered in 2005.